TRUMBULL, Conn., Sept. 20, 2016 -- ZetrOZ Systems, LLC, announced today that the company’s innovative FDA cleared wearable-active ultrasound device – called sam® Sport – is now used widely by professional athletic trainers and physiotherapists in the NFL, NBA, NHL, MLS, MLB and USA Teams.
Introduced to the healthcare market in 2014, sam® Sport is clinically proven to increase collagen laydown (accelerates the natural healing process in soft tissue), brings oxygenated blood to muscle tissues, accelerates angiogenesis (stimulates capillary development) and increases blood flow, which is important for muscle recovery, healing and healthy tissues.
sam® Sport (www.samsport.com) – manufactured in the United States and available by prescription from licensed healthcare professionals – is revolutionizing the treatment of soft-tissue injuries by significantly accelerating healing times, eliminating surgical procedures and reducing pain medication use.
Rick Guter, the head athletic trainer for USA Women’s Soccer, uses sam® Sport to treat both acute and chronic injuries. “For our soccer players we have a number of chronic groin muscle problems that have developed over time and this is one of the first devices that the athletes actually ask for,” he said.
Wally Blasé, former head athletic trainer for the NBA’s Atlanta Hawks and Chief Executive Officer of performance LLC works to rehabilitate professional athletes across the United States. “The key advantages of sam® Sport is the delivery of long-term ultrasound or sustained acoustic medicine, and to use it for deep-heat warming-up, recovery and treating injuries,” said Blasé. “The sam® Sport is nice, as you can put it on an athlete, set the timer and send them on their way.”
Beyond professional athletic programs, the medical device is growing in use among the general population and is covered by most worker’s compensation insurance carriers.
sam® Sport offers a non-invasive and non-addictive solution to eliminate America’s addiction to opioids and prescription drug abuse. George Lewis, Ph.D., Chief Executive Officer for ZetrOZ Systems, said: “The device is pre-approved by insurance for professional and collegiate athletes, and we have partnered with the largest insurance carriers to treat the workforce of America and get them off pain medication,” he explained. “The device allows the patient to obtain treatment while at work or on-the-go.”
sam® Sport is commonly prescribed for the non-invasive treatment of:
- Chronic tendinitis: elbow, bicep, tricep, shoulder;
- Shoulder/rotator cuff injuries and post-op recovery;
- Chronic back pain: lower back, sciatica and trapezius;
- Knee: meniscus tear and osteoarthritis (OA);
- Hamstring and groin strain and tears;
- Ankle injuries: sprain or frayed Achilles;
ZetrOZ Systems, LLC: ZetrOZ Systems, is a cGMP, ISO 13485 medical device manufacturer and sustained acoustic medicine pipeline development company. The company is the global leader in non-invasive medical devices to accelerate tissue healing and relieve pain for chronic musculoskeletal conditions.
For information, contact: Jim Molinaro Jr., chief commercial officer, ZetrOZ Systems LLC. [email protected] 888-507-8554


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Instagram Outage Disrupts Thousands of U.S. Users
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 



